MKP-1 mediates anti-inflammatory effects of the PDE4 inhibitor rolipram

被引：0
|
作者：
Korhonen, R.
Hommo, T.
Laavola, M.
Keranen, T.
Hamalainen, M.
Moilanen, E.
机构：
[1] Univ Tampere, Sch Med, Immunopharmacol Res Grp, FIN-33101 Tampere, Finland
[2] Tampere Univ Hosp, Tampere, Finland
来源：
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY | 2013年 / 42卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：427 / 428
页数：2
相关论文
共 50 条
  • [1] MKP-1 mediates anti-inflammatory effects of glucocorticoids in endothelial cells
    Fürst, R
    Zahler, S
    Vollmar, AM
    Kiemer, AK
    FASEB JOURNAL, 2005, 19 (04): : A733 - A733
  • [2] MKP-1 promotes anti-inflammatory M(IL-4/IL-13) macrophage phenotype and mediates the anti-inflammatory effects of glucocorticoids
    Pemmari, Antti
    Paukkeri, Erja-Leena
    Hamalainen, Mari
    Leppanen, Tiina
    Korhonen, Riku
    Moilanen, Eeva
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (04) : 404 - 415
  • [3] Anti-inflammatory effects of a PDE4 inhibitor in a rat model of chronic bronchitis.
    Gordon, T
    Frennette, R
    Ducharme, Y
    Pon, D
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A89 - A89
  • [4] Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site
    Christian Martin
    Rolf Göggel
    Vittorio Dal Piaz
    Claudia Vergelli
    Maria Giovannoni
    Martin Ernst
    Stefan Uhlig
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2002, 365 : 284 - 289
  • [5] Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site
    Martin, C
    Göggel, R
    Dal Piaz, V
    Vergelli, C
    Giovannoni, MP
    Ernst, M
    Uhlig, S
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (04) : 284 - 289
  • [6] Characterization of Anti-Inflammatory Effects of a PDE4 Inhibitor in a Model of Acute Smoke Exposure.
    Kubera, J. E.
    Schlerman, F. J.
    Nocka, K. H.
    Greco, R. M.
    Williams, C. M.
    Sypek, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [7] Pharmacological characterization of the discriminative stimulus effects of rolipram, a PDE4 inhibitor
    Makhay, MM
    O'Donnell, JM
    FASEB JOURNAL, 1998, 12 (04): : A135 - A135
  • [8] Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro
    Hatzelmann, A
    Schudt, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 267 - 279
  • [9] Association of the anti-inflammatory activity of phosphodiesterase 4 (PDE4) inhibitors with either inhibition of PDE4 catalytic activity or competition for [H-3]rolipram binding
    Barnette, MS
    Bartus, JOL
    Burman, M
    Christensen, SB
    Cieslinski, LB
    Esser, KM
    Prabhakar, US
    Rush, JA
    Torphy, TJ
    BIOCHEMICAL PHARMACOLOGY, 1996, 51 (07) : 949 - 956
  • [10] Mitogen-activated protein kinase phosphatase-1 (MKP-1) as a target of anti-inflammatory drug treatment: anti-inflammatory effects of the glucocorticoid dexamethasone are mediated by MKP-1 in murine models
    Nieminen, R.
    Pemmari, A.
    Hamalainen, M.
    Leppanen, T.
    Moilanen, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 : 5 - 6
12345